These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 27459623)
1. [Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia]. Gritsaev SV; Kostroma II; Zapreev IM; Shmidt AV; Tiranova SA; Balashova VA; Martynkevich IS; Chubukina ZV; Semenova NY; Chechetkin AV Ter Arkh; 2016; 88(7):104-108. PubMed ID: 27459623 [TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells. Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511 [TBL] [Abstract][Full Text] [Related]
3. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528 [TBL] [Abstract][Full Text] [Related]
4. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies. Kim SY; Song IC; Kim J; Kwon GC Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470 [TBL] [Abstract][Full Text] [Related]
5. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome. Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075 [TBL] [Abstract][Full Text] [Related]
6. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278 [TBL] [Abstract][Full Text] [Related]
7. Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic, and molecular study. Becher R; Carbonell F; Bartram CR Blood; 1990 Apr; 75(8):1679-83. PubMed ID: 2328318 [TBL] [Abstract][Full Text] [Related]
8. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959 [TBL] [Abstract][Full Text] [Related]
9. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis. Nakase K; Kita K; Kyo T; Katayama N Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287 [No Abstract] [Full Text] [Related]
11. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm. Fend F; Horn T; Koch I; Vela T; Orazi A Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525 [TBL] [Abstract][Full Text] [Related]
12. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML). Hackanson B; Rückert A; Lübbert M Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063 [No Abstract] [Full Text] [Related]
13. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
14. Atypical CML- the role of morphology and precision genomics. Lasho T Best Pract Res Clin Haematol; 2020 Jun; 33(2):101133. PubMed ID: 32460981 [TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide. Oka S; Ono K; Nohgawa M Leuk Lymphoma; 2017 Oct; 58(10):2511-2513. PubMed ID: 28278708 [No Abstract] [Full Text] [Related]
16. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities]. Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577 [TBL] [Abstract][Full Text] [Related]
17. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders. Hall J; Foucar K Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271 [TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndrome with Ph negative monosomy 7 chromosome following transient bone marrow dysplasia during imatinib treatment for chronic myeloid leukemia. Karimata K; Masuko M; Ushiki T; Kozakai T; Shibasaki Y; Yano T; Abe T; Moriyama M; Toba K; Furukawa T; Aizawa Y Intern Med; 2011; 50(5):481-5. PubMed ID: 21372464 [TBL] [Abstract][Full Text] [Related]
19. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Nardi V; Hasserjian RP Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274 [TBL] [Abstract][Full Text] [Related]
20. Atypical Chronic Myeloid Leukemia: Where Are We Now? Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]